Your search history is turned on.
Date: April 30, 2024 Jurisdictions: Alberta, British Columbia, Nova Scotia, Ontario
MedMira Announces the Hire of Vice President of Business Development HALIFAX, NOVA SCOTIA / ACCESSWIRE / April 30, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the position of Vice President of Business Development. Ms. Bell brings over 20 years of Business...
Date: April 1, 2024 Jurisdictions: Alberta, British Columbia, Nova Scotia, Ontario
Microsoft Word - IFRS_TSXV_Interim_E_MedMira CFO_Q2 2017.doc FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Markus M. Meile, CFO, MedMira Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of MedMira Inc. (the issuer) for the interim ...
Microsoft Word - IFRS_TSXV_Interim_E_MedMira CEO_Q2 2017.doc FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Hermes Chan, CEO, MedMira Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of MedMira Inc. (the issuer) for the interim peri...
Microsoft Word - MDA FY2024 Q2.docx MedMira Inc. Managements Discussion & Analysis For the six months ended January 31, 2024 Managements Discussion & Analysis For the six months ended January 31, 2024 1 Forward looking statements This document contains forward looking statements, such as stat...
Microsoft Word - MedMira Financial statements Q2 FY 2024.docx MedMira Inc. Condensed Interim Consolidated Financial Statements For the six months ended January 31, 2024 and January 31, 2023 (Unaudited Prepared by Management) In accordance with National Instrument 51-102 released by the Canadian Securities Administrators, th...
Microsoft Word - MedMira PR Q2 FY2024.docx MedMira Reports Second Quarter Results FY2024 Halifax, Nova Scotia, April 1, 2024 MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 claim on the Reveal G4 Rapid HI...
Date: March 13, 2024 Jurisdictions: Alberta, British Columbia, Nova Scotia, Ontario
Microsoft Word - Press Release March 2024.docx MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System Halifax, Nova Scotia, March 13, 2024 Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number 11,3...
Date: February 1, 2024 Jurisdictions: Alberta, British Columbia, Nova Scotia, Ontario
CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMiras Products Correction: Extended clarification. HALIFAX, NS / ACCESSWIRE / February 1, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) is pleased to provide an update on the ongoing review process by Health Canada. The Company made the submission and since then has been working with...
Corporate Update on Clinical Evaluation of MedMiras Products HALIFAX, NS / ACCESSWIRE / February 1, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) is pleased to provide an update on the ongoing review process by Health Canada. The Company made the required submission and has been working towards extending its intended use highlighting the increasing need ...
Date: January 15, 2024 Jurisdictions: Alberta, British Columbia, Nova Scotia, Ontario
Security Class Holder Account Number Form of Proxy - Annual General Meeting to be held on February 9, 2024 This Form of Proxy is solicited by and on behalf of Management. Notes to proxy 1. Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting or any ...